Rasha Mohammed Ali

Dr. Rasha Mohammed Ali


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
OAOmyma G. Ahmed
Omyma G. Ahmed
Ghaydaa ShehataGhaydaa Shehata
Ghaydaa Shehata
RARasha Mohammed Ali
Rasha Mohammed Ali
RMRania Makboul
Rania Makboul
Elsayed Fathi Abd_AllahElsayed Fathi Abd_Allah
Elsayed Fathi Abd_Allah
NMNessren Mahmoud
Nessren Mahmoud
The current study investigated the role of epigenetic dysregulation of brain derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) genes and oxidative stress as possible mechanisms of autistic-like behaviors in neonatal isolation model in rats and the impact of folic acid administration on these parameters. Forty Wistar albino pups were used as follows: control, folic acid administered, isolated, and isolated folic acid treated groups. Isolated pups were separated from their mothers for 90 min daily from postnatal day (PND) 1 to 11. Pups (isolated or control) received either the vehicle or folic acid (4 mg/kg/day) orally from PND 1 to 29. Behavioral tests were done from PND 30 to 35. Oxidative stress markers and antioxidant defense in the frontal cortex homogenate were determined. DNA methylation of BDNF and GFAP genes was determined by qPCR. Histopathological examination was carried out. Neonatal isolation produced autistic-like behaviors that were associated with BDNF and GFAP hypomethylation, increased oxidative stress, increased inflammatory cell infiltration, and structural changes in the frontal cortex. Folic acid administration concurrently with isolation reduced neonatal isolation-induced autistic-like behaviors, decreased oxidative stress, regained BDNF and GFAP gene methylation, and ameliorated structural changes in the frontal cortices of isolated folic acid treated rats. Novelty: Neonatal isolation induces “autistic-like” behavior and these behaviors are reversed by folic acid supplementation. Neonatal isolation induces DNA hypomethylation of BDNF and GFAP, increased oxidative stress markers, and neuroinflammation. All of these changes were reversed by daily folic acid supplementation.

27 August 2025 in Bulletin of Pharmaceutical Sciences Assiut University
Verified
Journal Article
Closed access
EAEsraa Abdel-Khalik Ahmed
Esraa Abdel-Khalik Ahmed
RARasha Mohammed Ali
Rasha Mohammed Ali
MMMarwa Hassan Bakr Mohamed
Marwa Hassan Bakr Mohamed
RERaghda Elsherif Mohamed Abd Elaziz
Raghda Elsherif Mohamed Abd Elaziz
AAAlaa Talaat Abdelhafez
Alaa Talaat Abdelhafez
Purpose: Neuropathic pain is characterized by poor treatment response. While previous studies on granulocyte colony-stimulating factor (GCSF) have primarily explored its effects on peripheral nerves, recent evidence suggests the central nervous system, particularly the brainstem pons, plays a crucial role in neuropathic pain modulation. This study investigated the effects of GCSF on the pons and sciatic nerve to alleviate neuropathic pain. Methods: Four groups of rats were created: the normal control, sham group, neuropathic group induced by chronic constriction injury of the sciatic nerve (CCI), and the GCSF-treated group received 50 μg/kg of GCSF subcutaneously starting on the 7th day of CCI for 5 consecutive days. Experimental testing for heat hyperalgesia, mechanical allodynia and mechanical hyperalgesia was performed. Immunohistochemical analyses were conducted to evaluate the central (pons) expression of glial fibrillary acidic protein (GFAP), proliferating cell nuclear antigen (PCNA), and S100 protein in the peripheral (sciatic nerve) tissues. Results: GCSF significantly alleviated heat hyperalgesia, mechanical allodynia, and mechanical hyperalgesia in CCI rats. In the pons, GCSF reduced GFAP expression, indicating inhibition of astrogliosis, and enhanced PCNA expression, suggesting promotion of neurogenesis. In the sciatic nerve, S100 expression was markedly elevated, implying enhanced remyelination. Conclusion: GCSF alleviates neuropathic pain not only by modulating peripheral nerve repair but also by inhibiting pontine astrogliosis and promoting central neuronal regeneration. These findings suggest GCSF may be a promising therapeutic agent for central and peripheral components of neuropathic pain.